Skip to main content
Year archive

China Resources Pharmaceutical Group Limited — 2024 filings

All 114 regulatory filings released by China Resources Pharmaceutical Group Limited (3320) in 2024, sourced directly from the official regulator.

114 Filings
2024 Period
2024 filings (114)
Filing Released Lang
CONTINUING CONNECTED TRANSACTIONS STRATEGIC COOPERATION AGREEMENTS 2025
Regulatory Filings
2024-12-31 English
CONTINUING CONNECTED TRANSACTIONS CR LEASING STRATEGIC COOPERATION AGREEMENT 2025
Regulatory Filings
2024-12-31 English
CONTINUING CONNECTED TRANSACTIONS THE PROCUREMENT FRAMEWORK AGREEMENT 2025 AND THE PRODUCTS AND COMMODITIES SALES FRAMEWORK AGREEMENT 2025
Regulatory Filings
2024-12-31 English
CONTINUING CONNECTED TRANSACTIONS THE IT SERVICES PROCUREMENT FRAMEWORK AGREEMENT 2025
Regulatory Filings
2024-12-30 English
CONTINUING CONNECTED TRANSACTIONS THE AMENDED BUSINESS TRAVEL SERVICES FRAMEWORK AGREEMENT 2025
Regulatory Filings
2024-12-30 English
TERMS OF REFERENCE FOR EXECUTIVE COMMITTEE (REVISED)
Governance Information
2024-12-27 English
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR SHENGHUO
M&A Activity
2024-12-20 English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY 1% AND SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER OF DONG-E-E-JIAO
Major Shareholding Notification
2024-12-18 English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY 1% AND SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER OF CR BOYA BIO-PHARMACEUTICAL
Major Shareholding Notification
2024-12-18 English
INSIDE INFORMATION ISSUANCE OF PERPETUAL BONDS IN THE PRC
Capital/Financing Update
2024-12-11 English
INSIDE INFORMATION REGISTRATION OF ASSET-BACKED NOTES BY THE NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS
Capital/Financing Update
2024-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Regulatory Filings
2024-12-02 English
VOLUNTARY ANNOUNCEMENT UPDATE ON THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR SHENGHUO
Capital/Financing Update
2024-11-21 English
DISCLOSEABLE TRANSACTION COMPLETION OF THE PROPOSED ACQUISITION OF GREEN CROSS HK
M&A Activity
2024-11-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Regulatory Filings
2024-11-01 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Regulatory Filings
2024-10-30 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Report Publication Announcement
2024-10-25 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF JIANGZHONG PHARMACEUTICAL FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Earnings Release
2024-10-25 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Regulatory Filings
2024-10-25 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Earnings Release
2024-10-25 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Regulatory Filings
2024-10-24 English
VOLUNTARY ANNOUNCEMENT SHAREHOLDING INCREASE PLAN BY THE CONTROLLING SHAREHOLDER OF JIANGZHONG PHARMACEUTICAL
Capital/Financing Update
2024-10-21 English
ANNOUNCEMENT RESULTS ESTIMATE OF DONG-E-E-JIAO FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Earnings Release
2024-10-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
Share Issue/Capital Change
2024-10-02 English
Notification of publication of corporate communications on the Company's website
Report Publication Announcement
2024-09-26 English
Letter to new shareholders - election of means of receipt of corporate communications
Regulatory Filings
2024-09-26 English
Letter to those shareholders who have elected to receive the corporate communications through the Company's website
Report Publication Announcement
2024-09-26 English
Letter to those shareholders who have elected to receive the printed form of corporate communications
Report Publication Announcement
2024-09-26 English
Interim Report 2024
Regulatory Filings
2024-09-26 English
DIVIDEND CURRENCY ELECTION FORM FOR THE INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024
Notice of Dividend Amount
2024-09-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
Regulatory Filings
2024-09-02 English
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2024
Notice of Dividend Amount
2024-08-29 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
Interim / Quarterly Report
2024-08-29 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2024-08-29 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR&#x3b; RESIGNATION OF CHIEF EXECUTIVE OFFICER&#x3b; AND CHANGE OF CHAIRMAN OF THE BOARD, CHAIRMAN OF THE NOMINATION COMMITTEE AND MEMBERS OF THE CORPORATE GOVERNAN
Board/Management Information
2024-08-29 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE SIX MONTHS ENDED 30 JUNE 2024
Earnings Release
2024-08-23 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE SIX MONTHS ENDED 30 JUNE 2024
Report Publication Announcement
2024-08-23 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE SIX MONTHS ENDED 30 JUNE 2024
Regulatory Filings
2024-08-22 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE SIX MONTHS ENDED 30 JUNE 2024
Interim / Quarterly Report
2024-08-22 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE SIX MONTHS ENDED 30 JUNE 2024
Interim / Quarterly Report
2024-08-21 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF JIANGZHONG PHARMACEUTICAL FOR THE SIX MONTHS ENDED 30 JUNE 2024
Interim / Quarterly Report
2024-08-21 English
DATE OF BOARD MEETING
Report Publication Announcement
2024-08-15 English
SUPPLEMENTARY ANNOUNCEMENT ON THE PROPOSED ACQUISITION OF GREEN CROSS HK
M&A Activity
2024-08-14 English
DISCLOSEABLE TRANSACTION PROPOSED ACQUISITION OF TASLY PHARMACEUTICALS
Capital/Financing Update
2024-08-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
Regulatory Filings
2024-08-01 English
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 31 JULY 2024
Declaration of Voting Results & Voting Rights Announcements
2024-07-31 English
CONTINUING CONNECTED TRANSACTIONS PROPERTY LEASING AND PROPERTY MANAGEMENT SERVICES FRAMEWORK AGREEMENT
Regulatory Filings
2024-07-23 English
(1) DISCLOSEABLE TRANSACTION PROPOSED ACQUISITION OF GREEN CROSS HK (2) STRATEGIC COOPERATION FRAMEWORK AGREEMENT
M&A Activity
2024-07-17 English
ANNOUNCEMENT RESULTS ESTIMATE OF DONG-E-E-JIAO FOR THE SIX MONTHS ENDED 30 JUNE 2024
Earnings Release
2024-07-12 English
DOCUMENTS ON DISPLAY - CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings
2024-07-11 English
Notification of publication of corporate communications on the Company's website
Report Publication Announcement
2024-07-11 English
Letter to new shareholders - election of means of receipt of corporate communications
Report Publication Announcement
2024-07-11 English
Letter to those shareholders who have elected to receive the corporate communications through the Company's website
Report Publication Announcement
2024-07-11 English
Letter to those shareholders who have elected to receive the printed form of corporate communications
Proxy Solicitation & Information Statement
2024-07-11 English
Proxy Form
Proxy Solicitation & Information Statement
2024-07-11 English
NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2024-07-11 English
CONTINUING CONNECTED TRANSACTIONS SALES FRAMEWORK AGREEMENT REVISION OF ANNUAL CAPS AND EXTENSION OF TERM AND NOTICE OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2024-07-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Regulatory Filings
2024-07-02 English
CONTINUING CONNECTED TRANSACTIONS ENERGY PURCHASE TRANSACTIONS
Regulatory Filings
2024-06-21 English
CONTINUING CONNECTED TRANSACTIONS SALES FRAMEWORK AGREEMENT REVISION OF ANNUAL CAPS AND EXTENSION OF TERM
Regulatory Filings
2024-06-17 English
DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023
Notice of Dividend Amount
2024-06-14 English
INSIDE INFORMATION THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR SHENGHUO
Capital/Financing Update
2024-06-11 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2024-06-07 English
CHANGE OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2024-06-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
Regulatory Filings
2024-06-03 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 30 MAY 2024
Declaration of Voting Results & Voting Rights Announcements
2024-05-30 English
CLARIFICATION ANNOUNCEMENT REVISED PROXY FORM FOR USE AT THE AGM TO BE HELD ON 30 MAY 2024
AGM Information
2024-05-28 English
Revised Proxy Form
Proxy Solicitation & Information Statement
2024-05-28 English
CONTINUING CONNECTED TRANSACTIONS COOPERATION AGREEMENT IN RELATION TO NEW ENERGY PROJECTS
Regulatory Filings
2024-05-16 English
CONTINUING CONNECTED TRANSACTIONS SUPPLY CHAIN MANAGEMENT SERVICES REVISION OF ANNUAL CAPS AND EXTENSION OF TERM
Regulatory Filings
2024-05-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Regulatory Filings
2024-05-02 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR PHARMACEUTICAL HOLDINGS FOR THE THREE MONTHS ENDED 31 MARCH 2024 IN RELATION TO ISSUANCES OF MEDIUM TERM NOTES AND CORPORATE BONDS IN THE PRC
Interim / Quarterly Report
2024-04-30 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF JIANGZHONG PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release
2024-04-29 English
JOINT ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS SUPPLY CHAIN MANAGEMENT SERVICES REVISION OF ANNUAL CAPS AND EXTENSION OF TERM
Regulatory Filings
2024-04-26 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release
2024-04-26 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release
2024-04-26 English
2023 Sustainability Report
Environmental & Social Information
2024-04-25 English
Notification of publication of corporate communications on the Company's website
Report Publication Announcement
2024-04-25 English
Letter to new shareholders - election of means of receipt of corporate communications
Regulatory Filings
2024-04-25 English
Letter to those shareholders who have elected to receive the corporate communications through the Company's website
Report Publication Announcement
2024-04-25 English
Letter to those shareholders who have elected to receive the printed form of corporate communications
Report Publication Announcement
2024-04-25 English
Proxy Form
Proxy Solicitation & Information Statement
2024-04-25 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2024-04-25 English
PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2024-04-25 English
2023 Annual Report
Regulatory Filings
2024-04-25 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information
2024-04-24 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release
2024-04-24 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE THREE MONTHS ENDED 31 MARCH 2024
Interim / Quarterly Report
2024-04-22 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release
2024-04-22 English
DISCLOSEABLE TRANSACTION PROGRESS UPDATE COMPLETION OF THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR ZIZHU
Capital/Financing Update
2024-04-18 English
INSIDE INFORMATION REGISTRATION AND COMPLETION OF THE PUBLIC ISSUANCE OF THE 2024 FIRST TRANCHE CORPORATE BONDS IN THE PRC
Capital/Financing Update
2024-04-17 English
CONTINUING CONNECTED TRANSACTIONS THE IT SERVICES PROCUREMENT FRAMEWORK AGREEMENT 2024
Regulatory Filings
2024-04-12 English
ANNOUNCEMENT RESULTS ESTIMATE OF DONG-E-E-JIAO FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release
2024-04-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Regulatory Filings
2024-04-02 English
Final Dividend for the Year Ended 31 December 2023
Notice of Dividend Amount
2024-03-26 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Annual Report
2024-03-26 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR BOYA BIO-PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2023
Report Publication Announcement
2024-03-25 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF JIANGZHONG PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2023
Report Publication Announcement
2024-03-25 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2023
Report Publication Announcement
2024-03-25 English
DISCLOSEABLE TRANSACTION THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR ZIZHU
Capital/Financing Update
2024-03-22 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF KPC FOR THE YEAR ENDED 31 DECEMBER 2023
Report Publication Announcement
2024-03-21 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF DONG-E-E-JIAO FOR THE YEAR ENDED 31 DECEMBER 2023
Report Publication Announcement
2024-03-21 English
ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR DOUBLE-CRANE FOR THE YEAR ENDED 31 DECEMBER 2023
Report Publication Announcement
2024-03-21 English
ANNOUNCEMENT PRELIMINARY FINANCIAL INFORMATION OF CR BOYA BIO-PHARMACEUTICAL FOR THE YEAR ENDED 31 DECEMBER 2023
Earnings Release
2024-03-13 English
DATE OF BOARD MEETING
Report Publication Announcement
2024-03-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Regulatory Filings
2024-03-01 English
INSIDE INFORMATION THE PROPOSED INTERNAL REORGANIZATION INVOLVING CR ZIZHU
Regulatory Filings
2024-02-23 English
CONNECTED TRANSACTION ENTRUSTED CONSTRUCTION AGREEMENT WITH SHENZHEN RUNZHI
Regulatory Filings
2024-02-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Regulatory Filings
2024-02-01 English
ANNOUNCEMENT KEY OPERATING DATA OF JIANGZHONG PHARMACEUTICAL FOR THE YEAR 2023
Earnings Release
2024-01-29 English
ANNOUNCEMENT RESULTS ESTIMATE OF DONG-E-E-JIAO FOR THE YEAR ENDED 31 DECEMBER 2023
Earnings Release
2024-01-26 English
ANNOUNCEMENT RESULTS ESTIMATE OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2023
Regulatory Filings
2024-01-24 English
DISCLOSEABLE TRANSACTION AND CONNECTED TRANSACTION COMPLETION OF THE PROPOSED INCREASE IN REGISTERED CAPITAL BY CR PHARMACEUTICAL COMMERCIAL
Capital/Financing Update
2024-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings
2024-01-02 English